Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
life sciences
national blog main
boston top stories
national top stories
san francisco blog main
san francisco top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco
abbvie
adeno-associated virus
alexandria venture investments
alkermes
allergan
altitude life science ventures
american society of gene and cell therapy
antidepressant
arch venture partners
assurex health
boulder/denver blog main
boulder/denver top stories
boxer capital
brca-1
brca-2
bryan dechairo
buprenorphine
cancer diagnostics
cariprazine
charles debattista
clinical trial
clinical trials
cymbalta
deals
depression
detroit blog main
detroit top stories
What
medicine
4
×
treatment
4
×
cancer
alkermes
announced
antipsychotic
area
based
bay
benefits
biopsy
blood
buildout
caveats
centers
close
commonly
company
crude
cut
cutting
depression
designed
despite
developing
drug
edge
effect
effects
encoded
event
favor
fda
firm
gain
gene
genetic
genomic
guesswork
guide
Language
unset
Current search:
treatment
×
medicine
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
